Your browser doesn't support javascript.
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations.
Habel, Jennifer R; Chua, Brendon Y; Kedzierski, Lukasz; Selva, Kevin J; Damelang, Timon; Haycroft, Ebene R; Nguyen, Thi Ho; Koay, Hui-Fern; Nicholson, Suellen; McQuilten, Hayley A; Jia, Xiaoxiao; Allen, Lilith F; Hensen, Luca; Zhang, Wuji; van de Sandt, Carolien E; Neil, Jessica A; Pragastis, Katherine; Lau, Jillian Sy; Jumarang, Jaycee; Allen, E Kaitlynn; Amanant, Fatima; Krammer, Florian; Wragg, Kathleen M; Juno, Jennifer A; Wheatley, Adam K; Tan, Hyon-Xhi; Pell, Gabrielle; Walker, Susan; Audsley, Jennifer; Reynaldi, Arnold; Thevarajan, Irani; Denholm, Justin T; Subbarao, Kanta; Davenport, Miles P; Hogarth, P Mark; Godfrey, Dale I; Cheng, Allen C; Tong, Steven Yc; Bond, Katherine; Williamson, Deborah A; McMahon, James H; Thomas, Paul G; Pannaraj, Pia S; James, Fiona; Holmes, Natasha E; Smibert, Olivia C; Trubiano, Jason A; Gordon, Claire L; Chung, Amy W; Whitehead, Clare L.
  • Habel JR; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Chua BY; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Kedzierski L; Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Japan.
  • Selva KJ; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Damelang T; Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia.
  • Haycroft ER; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Nguyen TH; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Koay HF; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Nicholson S; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • McQuilten HA; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Jia X; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Allen LF; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Hensen L; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Zhang W; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • van de Sandt CE; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Neil JA; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Pragastis K; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Lau JS; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Jumarang J; Department of Infectious Diseases, Alfred Health, Monash University, Melbourne, Victoria, Australia.
  • Allen EK; Department of Infectious Diseases, Alfred Health, Monash University, Melbourne, Victoria, Australia.
  • Amanant F; Department of Infectious Diseases, Eastern Health, Box Hill, Victoria, Australia.
  • Krammer F; Division of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Wragg KM; Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Juno JA; Department of Microbiology, and.
  • Wheatley AK; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Tan HX; Department of Microbiology, and.
  • Pell G; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Walker S; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Audsley J; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Reynaldi A; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, Victoria, Australia.
  • Thevarajan I; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Denholm JT; Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
  • Subbarao K; Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
  • Davenport MP; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Hogarth PM; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Godfrey DI; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Cheng AC; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Tong SY; Department of Infectious Diseases, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Bond K; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Williamson DA; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • McMahon JH; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Thomas PG; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Pannaraj PS; Immune Therapies Laboratory, Burnet Institute, Melbourne, Victoria, Australia.
  • James F; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Holmes NE; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia.
  • Smibert OC; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Trubiano JA; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Gordon CL; Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, and Monash Infectious Diseases, Monash Health, Melbourne, Victoria, Australia.
  • Chung AW; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Whitehead CL; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
JCI Insight ; 8(7)2023 04 10.
Article in English | MEDLINE | ID: covidwho-2296026
ABSTRACT
Pregnancy poses a greater risk for severe COVID-19; however, underlying immunological changes associated with SARS-CoV-2 during pregnancy are poorly understood. We defined immune responses to SARS-CoV-2 in unvaccinated pregnant and nonpregnant women with acute and convalescent COVID-19, quantifying 217 immunological parameters. Humoral responses to SARS-CoV-2 were similar in pregnant and nonpregnant women, although our systems serology approach revealed distinct antibody and FcγR profiles between pregnant and nonpregnant women. Cellular analyses demonstrated marked differences in NK cell and unconventional T cell activation dynamics in pregnant women. Healthy pregnant women displayed preactivated NK cells and γδ T cells when compared with healthy nonpregnant women, which remained unchanged during acute and convalescent COVID-19. Conversely, nonpregnant women had prototypical activation of NK and γδ T cells. Activation of CD4+ and CD8+ T cells and T follicular helper cells was similar in SARS-CoV-2-infected pregnant and nonpregnant women, while antibody-secreting B cells were increased in pregnant women during acute COVID-19. Elevated levels of IL-8, IL-10, and IL-18 were found in pregnant women in their healthy state, and these cytokine levels remained elevated during acute and convalescent COVID-19. Collectively, we demonstrate perturbations in NK cell and γδ T cell activation in unvaccinated pregnant women with COVID-19, which may impact disease progression and severity during pregnancy.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Female / Humans / Pregnancy Language: English Year: 2023 Document Type: Article Affiliation country: Jci.insight.167157

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Female / Humans / Pregnancy Language: English Year: 2023 Document Type: Article Affiliation country: Jci.insight.167157